Researchers at Carnegie Mellon University have developed an advanced nanomaterial-based biosensing platform that detects, within seconds, antibodies specific to SARS-CoV-2 or the coronavirus. It also helps to assess patient immunological response to the new vaccine. The study, published in the journal Advanced Materials, is Carnegie Mellon’s collaboration with the University of Pittsburgh (Pitt) and the UPMC. The testing platform identifies ...
Read More »